Avivagen Inc has signed a binding distribution agreement with Manila-based INPHILCO, Inc that will see the company become a distribution partner for OxC-beta Livestock in Philippines market
OxC-beta Livestock has the potential to eliminate the use of antibiotics as growth promoters in livestock feed, a problem requiring an urgent solution, and which represents a multi-hundred-million-dollar market opportunity worldwide.
Under the agreement, INPHILCO will be able to purchase OxC-beta directly from Avivagen and will hold the exclusive rights to sell the product to large integrated feed producers as an ingredient in its premixes and in its standalone form.
Kym Anthony, CEO at Avivagen, said, “INPHILCO brings a well-earned reputation for high-quality products and deep-rooted relationships with both large integrated feed producers and commercial farms to the table, which will set the stage for increased OxC-beta Livestock use for both swine and poultry in this very important region.”
The Philippines is a fast-growing and important feed market, with an estimated annual feed production of 18.2 mmt for 2020.
Swine and broiler poultry are the most important commercial livestock species in the country, representing approximately 82 per cent of all feed consumption. Avivagen expects continued growth within the Philippines and across the Asia-Pacific market as new applications of OxC-beta are being utilised by a growing number of local partners and as it pursues additional regulatory approvals in new jurisdictions.
